Ìý | Non-stroke Neck pain | Non-stroke Low back pain | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | Female | Male | Overall | Female | Male | |||||||
n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | |
Ìý | 16,197 | 17.80%(17.21–18.39) | 8567 | 23.43%(22.53–24.32) | 7630 | 11.48%(10.77–12.20) | 16,197 | 37.22%(36.47–37.96) | 8567 | 43.75%(42.70–44.80) | 7630 | 29.88%(28.85–30.91) |
Age, years | ||||||||||||
 45–54 | 4270 | 18.03%(16.88–19.19) | 2401 | 42.40%(40.42–44.38) | 1869 | 29.59%(27.52–31.66) | 4270 | 36.79%(35.34–38.24) | 2401 | 42.40%(40.42–44.38) | 1869 | 29.59%(27.52–31.66) |
 55–64 | 5535 | 18.68%(17.65–19.71) | 2880 | 42.92%(41.11–44.73) | 2655 | 30.02%(28.27–31.76) | 5535 | 36.73%(35.46–38.00) | 2880 | 42.92%(41.11–44.73) | 2655 | 30.02%(28.27–31.76) |
 65–74 | 4332 | 17.84%(16.70–18.98) | 2211 | 45.77%(43.69–47.85) | 2121 | 30.08%(28.13–32.03) | 4332 | 38.09%(36.64–39.54) | 2211 | 45.77%(43.69–47.85) | 2121 | 30.08%(28.13–32.03) |
 ≥ 75 | 2060 | 14.85%(13.32–16.39) | 1075 | 44.84%(41.86–47.81) | 985 | 29.64%(26.79–32.50) | 2060 | 37.57%(35.48–39.67) | 1075 | 44.84%(41.86–47.81) | 985 | 29.64%(26.79–32.50) |
 p value | Ìý | 0.002 | Ìý | 0.079 | Ìý | 0.983 | Ìý | 0.491 | Ìý | 0.079 | Ìý | 0.983 |
Residence | ||||||||||||
‼۳ܰù²¹±ô | 12,424 | 17.85%(17.18–18.53) | 6575 | 45.23%(44.03–46.44) | 5849 | 31.49%(30.30–32.68) | 12,424 | 38.76%(37.91–39.62) | 6575 | 45.23%(44.03–46.44) | 5849 | 31.49%(30.30–32.68) |
 u°ù²ú²¹²Ô | 3773 | 17.63%(16.41–18.84) | 1992 | 38.86%(36.71–41.00) | 1781 | 24.59%(22.59–26.59) | 3773 | 32.12%(30.63–33.61) | 1992 | 38.86%(36.71–41.00) | 1781 | 24.59%(22.59–26.59) |
 p value | Ìý | 0.749 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Education | ||||||||||||
 i±ô±ô¾±³Ù±ð°ù²¹³Ù±ð | 3795 | 20.66%(19.37–21.95) | 3024 | 45.21%(43.43–46.98) | 771 | 33.07%(29.75–36.40) | 3795 | 42.74%(41.17–44.32) | 3024 | 45.21%(43.43–46.98) | 771 | 33.07%(29.75–36.40) |
 elementary school or below | 6982 | 18.30%(17.40–19.21) | 3440 | 45.64%(43.97–47.30) | 3542 | 32.92%(31.37–34.47) | 6982 | 39.19%(38.04–40.33) | 3440 | 45.64%(43.97–47.30) | 3542 | 32.92%(31.37–34.47) |
 secondary school and above | 5420 | 15.15%(14.19–16.10) | 2103 | 38.56%(36.48–40.65) | 3317 | 25.90%(24.41–27.39) | 5420 | 30.81%(29.58–32.04) | 2103 | 38.56%(36.48–40.65) | 3317 | 25.90%(24.41–27.39) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Disability | ||||||||||||
 n´Ç | 14,356 | 16.50%(15.89–17.11) | 7590 | 42.00%(40.89–43.11) | 6766 | 28.26%(27.19–29.33) | 14,356 | 35.53%(34.74–36.31) | 7590 | 42.00%(40.89–43.11) | 6766 | 28.26%(27.19–29.33) |
 y±ð²õ | 1841 | 27.92%(25.87–29.97) | 977 | 57.32%(54.21–60.43) | 864 | 42.59%(39.29–45.90) | 1841 | 50.41%(48.12–52.69) | 977 | 57.32%(54.21–60.43) | 864 | 42.59%(39.29–45.90) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Chronic Disease | ||||||||||||
 0 | 9643 | 14.03%(13.34–14.72) | 5044 | 37.67%(36.33–39.01) | 4599 | 25.20%(23.95–26.46) | 9643 | 31.72%(30.79–32.65) | 5044 | 37.67%(36.33–39.01) | 4599 | 25.20%(23.95–26.46) |
 1 | 4355 | 20.48%(19.28–21.68) | 2315 | 50.19%(48.16–52.23) | 2040 | 34.02%(31.96–36.08) | 4355 | 42.62%(41.15–44.09) | 2315 | 50.19%(48.16–52.23) | 2040 | 34.02%(31.96–36.08) |
 2 | 2199 | 29.01%(27.11–30.91) | 1208 | 56.79%(53.99–59.59) | 991 | 43.09%(40.00–46.18) | 2199 | 50.61%(48.52–52.71) | 1208 | 56.79%(53.99–59.59) | 991 | 43.09%(40.00–46.18) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Sleep Time | ||||||||||||
 ≤ 6 h | 8838 | 22.22%(21.36–23.09) | 4952 | 49.41%(48.02–50.81) | 3886 | 34.82%(33.32–36.32) | 8838 | 43.00%(41.96–44.03) | 4952 | 49.41%(48.02–50.81) | 3886 | 34.82%(33.32–36.32) |
 6-8Ìýh | 5821 | 12.61%(11.76–13.46) | 2799 | 36.26%(34.48–38.05) | 3022 | 24.95%(23.41–26.49) | 5821 | 30.39%(29.21–31.57) | 2799 | 36.26%(34.48–38.05) | 3022 | 24.95%(23.41–26.49) |
 ≥ 8 h | 1538 | 12.03%(10.40–13.66) | 816 | 35.05%(31.77–38.33) | 722 | 23.96%(20.84–27.08) | 1538 | 29.84%(27.55–32.13) | 816 | 35.05%(31.77–38.33) | 722 | 23.96%(20.84–27.08) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Nap Time | ||||||||||||
 ≤ 30 min | 9039 | 19.04%(18.23–19.85) | 5185 | 45.36%(44.01–46.72) | 3854 | 31.16%(29.70–32.63) | 9039 | 39.31%(38.30–40.31) | 5185 | 45.36%(44.01–46.72) | 3854 | 31.16%(29.70–32.63) |
 31-60Ìýmin | 4087 | 17.37%(16.21–18.53) | 1995 | 42.16%(39.99–44.32) | 2092 | 28.06%(26.13–29.99) | 4087 | 34.94%(33.48–36.40) | 1995 | 42.16%(39.99–44.32) | 2092 | 28.06%(26.13–29.99) |
 ≥ 61 min | 3071 | 14.72%(13.46–15.97) | 1387 | 40.01%(37.43–42.60) | 1684 | 29.22%(27.04–31.39) | 3071 | 34.09%(32.42–35.77) | 1387 | 40.01%(37.43–42.60) | 1684 | 29.22%(27.04–31.39) |
 p value | Ìý | 0 | Ìý | 0.001 | Ìý | 0.035 | Ìý | 0 | Ìý | 0.001 | Ìý | 0.035 |
Dyspraxia | ||||||||||||
 n´Ç | 4986 | 7.44%(6.71–8.17) | 1903 | 19.65%(17.87–21.44) | 3083 | 16.67%(15.36–17.99) | 4986 | 17.81%(16.75–18.87) | 1903 | 19.65%(17.87–21.44) | 3083 | 16.67%(15.36–17.99) |
 y±ð²õ | 11,211 | 22.41%(21.63–23.18) | 6664 | 50.63%(49.43–51.83) | 4547 | 38.84%(37.42–40.26) | 11,211 | 45.85%(44.93–46.77) | 6664 | 50.63%(49.43–51.83) | 4547 | 38.84%(37.42–40.26) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Depressive | ||||||||||||
 n´Ç | 10,762 | 12.70%(12.07–13.33) | 5170 | 35.16%(33.86–36.47) | 5592 | 24.46%(23.34–25.59) | 10,762 | 29.60%(28.74–30.47) | 5170 | 35.16%(33.86–36.47) | 5592 | 24.46%(23.34–25.59) |
 y±ð²õ | 5435 | 27.89%(26.70–29.09) | 3397 | 56.81%(55.15–58.48) | 2038 | 44.75%(42.59–46.91) | 5435 | 52.29%(50.96–53.62) | 3397 | 56.81%(55.15–58.48) | 2038 | 44.75%(42.59–46.91) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Drink | ||||||||||||
 n´Ç | 10,683 | 19.67%(18.91–20.42) | 7362 | 43.10%(41.97–44.23) | 3321 | 30.08%(28.52–31.64) | 10,683 | 39.05%(38.13–39.98) | 7362 | 43.10%(41.97–44.23) | 3321 | 30.08%(28.52–31.64) |
 y±ð²õ | 5514 | 14.18%(13.26–15.10) | 1205 | 47.72%(44.89–50.54) | 4309 | 29.73%(28.36–31.09) | 5514 | 33.66%(32.41–34.91) | 1205 | 47.72%(44.89–50.54) | 4309 | 29.73%(28.36–31.09) |
 p value | Ìý | 0 | Ìý | 0.003 | Ìý | 0.739 | Ìý | 0 | Ìý | 0.003 | Ìý | 0.739 |
ADL | ||||||||||||
 n´Ç | 13,397 | 14.50%(13.90–15.09) | 6780 | 38.19%(37.03–39.34) | 6617 | 26.82%(25.76–27.89) | 13,397 | 32.57%(31.78–33.37) | 6780 | 38.19%(37.03–39.34) | 6617 | 26.82%(25.76–27.89) |
 y±ð²õ | 2800 | 33.61%(31.86–35.36) | 1787 | 64.86%(62.64–67.07) | 1013 | 49.85%(46.77–52.94) | 2800 | 59.43%(57.61–61.25) | 1787 | 64.86%(62.64–67.07) | 1013 | 49.85%(46.77–52.94) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
ADL_ins | ||||||||||||
 n´Ç | 12,561 | 14.44%(13.83–15.06) | 6205 | 37.60%(36.39–38.80) | 6356 | 26.83%(25.74–27.91) | 12,561 | 32.15%(31.33–32.96) | 6205 | 37.60%(36.39–38.80) | 6356 | 26.83%(25.74–27.91) |
 y±ð²õ | 3636 | 29.40%(27.92–30.88) | 2362 | 59.91%(57.93–61.88) | 1274 | 45.13%(42.40–47.87) | 3636 | 54.73%(53.11–56.35) | 2362 | 59.91%(57.93–61.88) | 1274 | 45.13%(42.40–47.87) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Activity_intensive | ||||||||||||
 less than 10Ìýmin | 10,895 | 17.66%(16.94–18.38) | 6223 | 41.68%(40.46–42.91) | 4672 | 26.84%(25.57–28.11) | 10,895 | 35.32%(34.42–36.22) | 6223 | 41.68%(40.46–42.91) | 4672 | 26.84%(25.57–28.11) |
 More than 10Ìýmin | 5302 | 18.09%(17.05–19.12) | 2344 | 49.23%(47.21–51.26) | 2958 | 34.69%(32.97–36.40) | 5302 | 41.12%(39.79–42.44) | 2344 | 49.23%(47.21–51.26) | 2958 | 34.69%(32.97–36.40) |
 p value | Ìý | 0.504 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 |
Activity_moderate | ||||||||||||
 less than 10Ìýmin | 8146 | 15.39%(14.61–16.18) | 3882 | 41.19%(39.64–42.74) | 4264 | 28.68%(27.32–30.04) | 8146 | 34.64%(33.61–35.68) | 3882 | 41.19%(39.64–42.74) | 4264 | 28.68%(27.32–30.04) |
 More than 10Ìýmin | 8051 | 20.23%(19.36–21.11) | 4685 | 45.87%(44.44–47.30) | 3366 | 31.40%(29.83–32.97) | 8051 | 39.82%(38.75–40.89) | 4685 | 45.87%(44.44–47.30) | 3366 | 31.40%(29.83–32.97) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0.001 | Ìý | 0 | Ìý | 0 | Ìý | 0.01 |
Activity_light | ||||||||||||
 less than 10Ìýmin | 2769 | 16.90%(15.50–18.30) | 1479 | 44.62%(42.09–47.16) | 1290 | 27.83%(25.38–30.28) | 2769 | 36.80%(35.00–38.60) | 1479 | 44.62%(42.09–47.16) | 1290 | 27.83%(25.38–30.28) |
 More than 10Ìýmin | 13,428 | 17.98%(17.34–18.63) | 7088 | 43.57%(42.41–44.72) | 6340 | 30.30%(29.17–31.43) | 13,428 | 37.30%(36.48–38.12) | 7088 | 43.57%(42.41–44.72) | 6340 | 30.30%(29.17–31.43) |
 p value | Ìý | 0.175 | Ìý | 0.456 | Ìý | 0.077 | Ìý | 0.619 | Ìý | 0.456 | Ìý | 0.077 |
Treatments for Stroke | ||||||||||||
 n´Ç | 16,197 | Ìý | 8567 | Ìý | 7630 | Ìý | 16,197 | Ìý | 8567 | Ìý | 7630 | Ìý |
 y±ð²õ | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý | 0 | Ìý |
 p value | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý | Ìý |
Ìý | Stroke Neck pain | Stroke Low back pain | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | Female | Male | Overall | Female | Male | |||||||
n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | n | Prevalence (95%CI) | |
Ìý | 885 | 26.44% (23.53–29.35) | 457 | 33.70%(29.35–38.05) | 428 | 18.69%(14.98–22.40) | 885 | 45.42% (42.14–48.71) | 457 | 57.33%(52.78–61.88) | 428 | 32.71%(28.25–37.17) |
Age, years | ||||||||||||
 45–54 | 82 | 29.27%(19.21–39.33) | 40 | 40%(24.13–55.87) | 42 | 19.05%(6.66–31.43) | 82 | 47.56%(36.52–58.60) | 40 | 55%(38.89–71.13) | 42 | 40.48%(24.99–55.96) |
 55–64 | 260 | 25%(19.70–30.30) | 126 | 30.95%(22.77–39.14) | 134 | 19.40%(12.62–26.19) | 260 | 46.15%(40.05–52.25) | 126 | 61.11%(52.48–69.74) | 134 | 32.09%(24.08–40.10) |
 65–74 | 351 | 28.77%(24.02–33.53) | 196 | 35.71%(28.95–42.48) | 155 | 20%(13.63–26.37) | 351 | 45.58%(40.35–50.82) | 196 | 57.65%(50.67–64.63) | 155 | 30.32%(23.01–37.64) |
 ≥ 75 | 192 | 22.92%(16.92–28.92) | 95 | 30.53%(21.10–39.96) | 97 | 15.46%(8.14–22.79) | 192 | 43.23%(36.16–50.30) | 95 | 52.63%(42.41–62.86) | 97 | 34.02%(24.42–43.62) |
 p value | Ìý | 0.421 | Ìý | 0.591 | Ìý | 0.83 | Ìý | 0.901 | Ìý | 0.641 | Ìý | 0.65 |
Residence | ||||||||||||
‼۳ܰù²¹±ô | 653 | 26.19%(22.81–29.57) | 338 | 32.84%(27.81–37.87) | 315 | 19.05%(14.69–23.41) | 653 | 46.40%(42.57–50.24) | 338 | 57.69%(52.40–62.99) | 315 | 34.29%(29.02–39.56) |
 u°ù²ú²¹²Ô | 232 | 27.16%(21.39–32.92) | 119 | 36.13%(27.38–44.89) | 113 | 17.70%(10.55–24.84) | 232 | 42.67%(36.26–49.08) | 119 | 56.30%(47.26–65.34) | 113 | 28.32%(19.88–36.75) |
 p value | Ìý | 0.774 | Ìý | 0.514 | Ìý | 0.753 | Ìý | 0.328 | Ìý | 0.793 | Ìý | 0.247 |
Education | ||||||||||||
 i±ô±ô¾±³Ù±ð°ù²¹³Ù±ð | 245 | 28.98%(23.26–34.70) | 185 | 29.73%(23.08–36.38) | 60 | 26.67%(15.15–38.19) | 245 | 53.47%(47.18–59.76) | 185 | 58.38%(51.21–65.55) | 60 | 38.33%(25.67–51.00) |
 elementary school or below | 379 | 31.40%(26.70–36.09) | 190 | 40%(32.97–47.03) | 189 | 22.75%(16.72–28.78) | 379 | 49.34%(44.28–54.40) | 190 | 61.05%(54.06–68.05) | 189 | 37.57%(30.60–44.53) |
 secondary school and above | 261 | 16.86%(12.29–21.43) | 82 | 28.05%(18.12–37.98) | 179 | 11.73(6.97–16.49) | 261 | 32.18%(26.48–37.89) | 82 | 46.34%(35.32–57.37) | 179 | 25.70%(19.24–32.16) |
 p value | Ìý | 0 | Ìý | 0.054 | Ìý | 0.006 | Ìý | 0 | Ìý | 0.074 | Ìý | 0.032 |
Disability | ||||||||||||
 n´Ç | 628 | 24.84%(21.45–28.23) | 325 | 31.69%(26.61–36.78) | 303 | 17.49%(13.19–21.79) | 628 | 44.11%(40.21–48.00) | 325 | 55.08%(49.64–60.51) | 303 | 32.34%(27.05–37.64) |
 y±ð²õ | 257 | 30.35%(24.69–36.01) | 132 | 38.64%(30.22–47.05) | 125 | 21.60%(14.29–28.91) | 257 | 48.64%(42.49–54.79) | 132 | 62.88%(54.53–71.22) | 125 | 33.60%(25.20–42.00) |
 p value | Ìý | 0.092 | Ìý | 0.155 | Ìý | 0.323 | Ìý | 0.22 | Ìý | 0.127 | Ìý | 0.802 |
Chronic Disease | ||||||||||||
 0 | 350 | 21.43%(17.11–25.75) | 177 | 29.38%(22.60–36.15) | 173 | 13.29%(8.18–18.40) | 350 | 38.57%(33.45–43.70) | 177 | 53.11%(45.68–60.53) | 173 | 23.70%(17.30–30.10) |
 1 | 282 | 26.60%(21.41–31.78) | 146 | 34.93%(27.11–42.76) | 136 | 17.65%(11.16–24.14) | 282 | 43.97%(38.14–49.80) | 146 | 54.11%(45.93–62.29) | 136 | 33.09%(25.08–41.10) |
 2 | 253 | 33.20%(27.36–39.04) | 134 | 38.06%(29.73–46.39) | 119 | 27.73%(19.57–35.89) | 253 | 56.52%(50.37–62.67) | 134 | 66.42%(58.32–74.52) | 119 | 45.38%(36.30–54.45) |
 p value | Ìý | 0.005 | Ìý | 0.258 | Ìý | 0.007 | Ìý | 0 | Ìý | 0.04 | Ìý | 0.001 |
Sleep Time | ||||||||||||
 ≤ 6 h | 509 | 33.99%(29.86–38.12) | 289 | 41.87%(36.15–47.59) | 220 | 23.64%(17.98–29.29) | 509 | 50.29%(45.93–54.65) | 289 | 59.86%(54.18–65.55) | 220 | 37.73%(31.27–44.18) |
 6-8Ìýh | 275 | 16.36%(11.96–20.76) | 126 | 20.63%(13.47–27.80) | 149 | 12.75%(7.33–18.17) | 275 | 38.18%(32.40–43.96) | 126 | 52.38%(43.54–61.22) | 149 | 26.17%(19.03–33.31) |
 ≥ 8 h | 101 | 15.84%(8.60–23.09) | 42 | 16.67%(4.91–28.42) | 59 | 15.25%(5.80–24.70) | 101 | 40.59%(30.85–50.33) | 42 | 54.76%(39.06–70.46) | 59 | 30.51%(18.41–42.61) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0.024 | Ìý | 0.003 | Ìý | 0.346 | Ìý | 0.063 |
Nap Time | ||||||||||||
 ≤ 30 min | 455 | 30.11%(25.88–34.34) | 258 | 36.82%(30.90–42.75) | 197 | 21.32%(15.55–27.09) | 455 | 49.67%(45.06–54.28) | 258 | 58.53%(52.48–64.58) | 197 | 38.07%(31.23–44.91) |
 31-60Ìýmin | 200 | 19.50%(13.96–25.04) | 102 | 26.47%(17.76–35.18) | 98 | 12.24%(5.64–18.85) | 200 | 44.00%(37.06–50.94) | 102 | 62.75%(53.20–72.29) | 98 | 24.49%(15.82–33.16) |
 ≥ 61 min | 230 | 25.22%(19.56–30.87) | 97 | 32.99%(23.46–42.52) | 133 | 19.55%(12.72–26.38) | 230 | 38.26%(31.93–44.59) | 97 | 48.45%(38.33–58.58) | 133 | 30.83%(22.88–38.78) |
 p value | Ìý | 0.016 | Ìý | 0.172 | Ìý | 0.163 | Ìý | 0.016 | Ìý | 0.106 | Ìý | 0.055 |
Dyspraxia | ||||||||||||
 n´Ç | 104 | 10.58%(4.57–16.59) | 26 | 11.54%(-1.62–24.70) | 78 | 10.26%(3.37–17.14) | 104 | 18.27%(10.72–25.82) | 26 | 26.92%(8.65–45.19) | 78 | 15.38%(7.20–23.57) |
 y±ð²õ | 781 | 28.55%(25.38–31.73) | 431 | 35.03%(30.51–39.56) | 350 | 20.57%(16.32–24.83) | 781 | 49.04%(45.53–52.55) | 431 | 59.16%(54.51–63.82) | 350 | 36.57%(31.50–41.64) |
 p value | Ìý | 0 | Ìý | 0.014 | Ìý | 0.035 | Ìý | 0 | Ìý | 0.001 | Ìý | 0 |
Depressive | ||||||||||||
 n´Ç | 506 | 19.76%(16.28–23.24) | 231 | 24.68%(19.07–30.28) | 275 | 15.64%(11.32–19.96) | 506 | 35.57%(31.39–39.76) | 231 | 45.89%(39.41–52.36) | 275 | 26.91%(21.63–32.18) |
 y±ð²õ | 379 | 35.36%(30.52–40.19) | 226 | 42..92%(36.42–49.42) | 153 | 24.18%(17.32–31.04) | 379 | 58.58%(53.59–63.56) | 226 | 69.03%(62.95–75.10) | 153 | 43.14%(35.20–51.07) |
 p value | Ìý | 0 | Ìý | 0 | Ìý | 0.03 | Ìý | 0 | Ìý | 0 | Ìý | 0.001 |
Drink | ||||||||||||
 n´Ç | 683 | 28.26%(24.87–31.64) | 417 | 32.85%(28.33–37.38) | 266 | 21.05%(16.12–25.98) | 683 | 46.71%(42.95–50.46) | 417 | 55.88%(51.09–60.67) | 266 | 32.33%(26.67–37.99) |
 y±ð²õ | 202 | 20.30%(14.70–25.89) | 40 | 42.50%(26.49–58.51) | 162 | 14.81%(9.29–20.34) | 202 | 41.09%(34.25–47.93) | 40 | 72.50%(58.04–86.96) | 162 | 33.33%(26.00–40.67) |
 p value | Ìý | 0.024 | Ìý | 0.219 | Ìý | 0.109 | Ìý | 0.159 | Ìý | 0.042 | Ìý | 0.831 |
ADL | ||||||||||||
 n´Ç | 508 | 21.85%(18.24–25.46) | 229 | 30.57%(24.56–36.58) | 279 | 14.70%(10.52–18.88) | 508 | 39.57%(35.30–43.83) | 229 | 55.46%(48.97–61.94) | 279 | 26.52%(21.31–31.74) |
 y±ð²õ | 377 | 32.63%(27.87–37.38) | 228 | 36.84%(30.53–43.15) | 149 | 26.17%(19.03–33.31) | 377 | 53.32%(48.26–58.37) | 228 | 59.21%(52.78–65.64) | 149 | 44.30%(36.23–52.36) |
 p value | Ìý | 0 | Ìý | 0.157 | Ìý | 0.004 | Ìý | 0 | Ìý | 0.419 | Ìý | 0 |
ADL_ins | ||||||||||||
 n´Ç | 426 | 22.07%(18.11–26.02) | 183 | 28.96%(22.33–35.60) | 243 | 16.87%(12.13–21.61) | 426 | 38.03%(33.40–42.66) | 183 | 48.63%(41.32–55.94) | 243 | 30.04%(24.24–35.85) |
 y±ð²õ | 459 | 30.50%(26.27–34.73) | 274 | 36.86%(31.11–42.61) | 185 | 21.08%(15.15–27.01) | 459 | 52.29%(47.70–56.87) | 274 | 63.14%(57.39–68.89) | 185 | 36.22%(29.23–43.21) |
 p value | Ìý | 0.004 | Ìý | 0.08 | Ìý | 0.27 | Ìý | 0 | Ìý | 0.002 | Ìý | 0.178 |
Activity_intensive | ||||||||||||
 less than 10Ìýmin | 705 | 25.11%(21.90–28.32) | 376 | 31.91%(27.18–36.65) | 329 | 17.33%(13.21–21.44) | 705 | 43.55%(39.88–47.21) | 376 | 55.32%(50.27–60.37) | 329 | 30.09%(25.11–35.07) |
 More than 10Ìýmin | 180 | 31.67%(24.81–38.53) | 81 | 41.98%(30.99–52.96) | 99 | 23.23%(14.77–31.70) | 180 | 52.78%(45.41–60.14) | 81 | 66.67%(56.18–77.16) | 99 | 41.41%(31.54–51.29) |
 p value | Ìý | 0.075 | Ìý | 0.083 | Ìý | 0.187 | Ìý | 0.15 | Ìý | 0.061 | Ìý | 0.035 |
Activity_moderate | ||||||||||||
 less than 10Ìýmin | 559 | 24.87%(21.27–28.46) | 267 | 31.84%(26.21–37.46) | 292 | 18.49%(14.01–22.97) | 559 | 42.75%(38.64–46.87) | 267 | 55.81%(49.81–61.80) | 292 | 30.82%(25.49–36.15) |
 More than 10Ìýmin | 326 | 29.14%(24.18–34.10) | 190 | 36.32%(29.42–43.22) | 136 | 19.12%(12.42–25.81) | 326 | 50%(44.54–55.46) | 190 | 59.47%(52.43–66.52) | 136 | 36.76%(28.56–44.97) |
 p value | Ìý | 0.165 | Ìý | 0.319 | Ìý | 0.878 | Ìý | 0.037 | Ìý | 0.436 | Ìý | 0.223 |
Activity_light | ||||||||||||
 less than 10Ìýmin | 211 | 24.17%(18.35–29.99) | 132 | 28.03%(20.27–35.79) | 79 | 17.72%(9.11–26.33) | 211 | 47.39%(40.60–54.19) | 132 | 54.55%(45.94–63.15) | 79 | 35.44%(24.66–46.23) |
 More than 10Ìýmin | 674 | 27.15%(23.79–30.52) | 325 | 36%(30.75–41.25) | 349 | 18.91%(14.78–23.04) | 674 | 44.81%(41.04–48.57) | 325 | 58.46%(53.08–63.85) | 349 | 32.09%(27.17–37.01) |
 p value | Ìý | 0.392 | Ìý | 0.103 | Ìý | 0.807 | Ìý | 0.511 | Ìý | 0.444 | Ìý | 0.568 |
Treatments for Stroke | ||||||||||||
 n´Ç | 232 | 22.41%(17.01–27.82) | 124 | 29.84%(21.67–38.01) | 108 | 13.89%(7.26–20.52) | 232 | 43.10%(36.68–49.52) | 124 | 52.42%(43.51–61.33) | 108 | 32.41%(23.44–41.38) |
 y±ð²õ | 653 | 27.87%(24.42–31.32) | 333 | 35.14%(29.98–40.29) | 320 | 20.31%(15.88–24.74) | 653 | 46.25%(42.41–50.08) | 333 | 59.16%(53.85–64.47) | 320 | 32.81%(27.64–37.98) |
 p value | Ìý | 0.106 | Ìý | 0.288 | Ìý | 0.139 | Ìý | 0.409 | Ìý | 0.196 | Ìý | 0.938 |